See more : Ivanhoe Mines Ltd. (IVPAF) Income Statement Analysis – Financial Results
Complete financial analysis of Reflect Scientific, Inc. (RSCF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Reflect Scientific, Inc., a leading company in the Medical – Instruments & Supplies industry within the Healthcare sector.
- Top Ramdor Systems & Computers Co. (1990) Ltd (TOPS.TA) Income Statement Analysis – Financial Results
- Orinoquia Real Estate SOCIMI, S.A. (MLORQ.PA) Income Statement Analysis – Financial Results
- Enchem Co., Ltd. (348370.KQ) Income Statement Analysis – Financial Results
- Business First Bancshares, Inc. (BFST) Income Statement Analysis – Financial Results
- Amines & Plasticizers Limited (AMNPLST.NS) Income Statement Analysis – Financial Results
Reflect Scientific, Inc. (RSCF)
Industry: Medical - Instruments & Supplies
Sector: Healthcare
Website: https://www.reflectscientific.com
About Reflect Scientific, Inc.
Reflect Scientific, Inc. designs, develops, and sells scientific equipment for the life science and manufacturing industries worldwide. The company offers Cryometrix ultra low temperature and blast freezers, which are used to store various products, including blood and cancer vaccines. It also provides laboratory consumables and disposables, such as filtration and purification products, customized sample handling vials, electronic wiring assemblies, high temperature silicone, and graphite and vespel/graphite sealing components for use by original equipment manufacturers in the field of gas/liquid chromatography in the chemical analysis industries. In addition, the company offers solvent chillers and refrigerated transportation products. It serves hospitals diagnostic laboratories, pharmaceutical and biotech companies, universities, government, and private sector research facilities, as well as cold chain management, chemical, and industrial companies. Reflect Scientific, Inc. is based in Orem, Utah.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.08M | 2.04M | 2.81M | 2.79M | 1.61M | 1.55M | 1.07M | 1.19M | 1.04M | 1.53M | 1.29M | 1.33M | 1.99M | 2.40M | 5.66M | 10.13M | 8.02M | 2.57M | 2.24M | 2.10M |
| Cost of Revenue | 483.73K | 822.15K | 884.07K | 1.07M | 617.60K | 487.19K | 405.94K | 376.06K | 407.11K | 678.30K | 618.04K | 617.78K | 989.45K | 1.31M | 3.44M | 5.50M | 4.63M | 1.52M | 1.32M | 1.28M |
| Gross Profit | 596.42K | 1.22M | 1.93M | 1.72M | 991.64K | 1.06M | 659.84K | 812.55K | 630.21K | 849.63K | 668.98K | 711.27K | 997.89K | 1.09M | 2.22M | 4.63M | 3.39M | 1.05M | 917.19K | 821.81K |
| Gross Profit Ratio | 55.22% | 59.72% | 68.59% | 61.64% | 61.62% | 68.61% | 61.91% | 68.36% | 60.75% | 55.61% | 51.98% | 53.52% | 50.21% | 45.37% | 39.18% | 45.68% | 42.23% | 40.94% | 40.93% | 39.07% |
| Research & Development | 29.54K | 73.43K | 58.34K | 185.30K | 210.01K | 104.05K | 46.70K | 70.80K | 72.86K | 22.14K | 37.16K | 35.95K | 33.17K | 7.62K | 307.43K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 388.64K | 1.06M | 1.04M | 885.00K | 976.46K | 1.21M | 1.02M | 993.35K | 1.02M | 1.55M | 1.32M | 1.09M | 1.56M | 1.17M | 4.38M | 0.00 | 3.45M | 1.30M | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 17.10K | 16.32K | 22.33K | 0.00 | 0.00 | 0.00 | 0.00 | 5.35M | 842.49K | 0.00 | 0.00 |
| SG&A | 388.64K | 1.06M | 1.04M | 885.00K | 976.46K | 1.21M | 1.02M | 993.35K | 1.02M | 1.55M | 1.32M | 1.09M | 1.56M | 1.17M | 4.38M | 5.16M | 8.80M | 2.15M | 823.37K | 697.32K |
| Other Expenses | 0.00 | 0.00 | 111.27K | 10.00K | 0.00 | 137.45K | 280.92K | 276.29K | 289.24K | 183.31K | 273.81K | 2.32M | 0.00 | 422.97K | 0.00 | 0.00 | 716.25K | 35.41K | 29.50K | 0.00 |
| Operating Expenses | 1.06M | 1.13M | 1.10M | 1.07M | 1.19M | 1.31M | 1.06M | 1.06M | 1.09M | 1.57M | 1.35M | 1.12M | 1.60M | 1.18M | 4.69M | 5.16M | 8.80M | 2.18M | 852.86K | 697.32K |
| Cost & Expenses | 1.55M | 1.95M | 1.99M | 2.14M | 1.80M | 1.80M | 1.47M | 1.44M | 1.50M | 2.25M | 1.97M | 1.74M | 2.59M | 2.49M | 8.13M | 10.66M | 13.43M | 3.70M | 2.18M | 1.98M |
| Interest Income | 0.00 | 0.00 | 0.00 | 890.00 | 755.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 0.00 | 0.00 | 890.00 | 755.00 | 661.00 | 0.00 | 314.00 | 59.49K | 123.19K | 118.07K | 315.80K | 534.46K | 535.31K | 1.01M | 1.60M | 1.41M | 25.00 | 9.26K | 12.16K |
| Depreciation & Amortization | 61.49K | 56.22K | 57.16K | 62.34K | 3.98K | 2.98K | 5.32K | 5.32K | 28.73K | 40.37K | 47.56K | 287.67K | 331.05K | 343.98K | 549.99K | 1.72M | 1.06M | 134.41K | 8.90K | 3.41K |
| EBITDA | -405.78K | 146.32K | 996.22K | 723.35K | -190.85K | -245.88K | -402.19K | -210.57K | -431.23K | -677.26K | -847.57K | 804.39K | -321.46K | 254.89K | -2.47M | 1.18M | -4.33M | -993.67K | 67.62K | 127.90K |
| EBITDA Ratio | -37.57% | 7.17% | 35.39% | 25.90% | -11.86% | -15.84% | -37.74% | -20.72% | -41.57% | -44.39% | -49.41% | -9.38% | -13.48% | 10.61% | -33.92% | 11.61% | -54.45% | -31.12% | 3.27% | 6.08% |
| Operating Income | -467.28K | 90.10K | 827.80K | 651.01K | -194.83K | -248.86K | -402.19K | -251.60K | -459.95K | -718.60K | -898.68K | -2.91M | -706.92K | -89.10K | -2.47M | -535.03K | -5.41M | -1.13M | 64.32K | 124.49K |
| Operating Income Ratio | -43.26% | 4.41% | 29.41% | 23.31% | -12.11% | -16.04% | -37.74% | -21.17% | -44.34% | -47.03% | -69.83% | -219.12% | -35.57% | -3.71% | -43.64% | -5.28% | -67.46% | -43.86% | 2.87% | 5.92% |
| Total Other Income/Expenses | 8.56K | 0.00 | 111.27K | 9.11K | -755.00 | -661.00 | 0.00 | 35.41K | 1.30M | -122.21K | -114.52K | 613.27K | -480.05K | -535.30K | -2.41M | -1.59M | -1.39M | -192.94K | -9.26K | -12.16K |
| Income Before Tax | -458.72K | 90.10K | 939.07K | 660.12K | -195.59K | -249.52K | -402.19K | -216.20K | 835.94K | -840.81K | -1.01M | 200.92K | -1.19M | -624.40K | -4.88M | -2.13M | -6.80M | -1.32M | 55.06K | 112.33K |
| Income Before Tax Ratio | -42.47% | 4.41% | 33.36% | 23.64% | -12.15% | -16.08% | -37.74% | -18.19% | 80.59% | -55.03% | -78.72% | 15.12% | -59.73% | -26.00% | -86.23% | -20.99% | -84.77% | -51.36% | 2.46% | 5.34% |
| Income Tax Expense | 312.00 | 702.00 | 111.27K | 10.89K | 755.00 | -158.16K | -411.25K | 314.00 | 59.49K | 123.19K | 118.07K | 315.80K | 534.46K | 1.15M | 3.12K | 38.90K | 278.00K | -342.75K | 16.90K | 69.71K |
| Net Income | -459.03K | 89.40K | 939.07K | 660.12K | -196.34K | -249.52K | -402.19K | -216.20K | 835.94K | -840.81K | -1.01M | 200.92K | -1.19M | -1.77M | -4.88M | -2.16M | -7.08M | -978.63K | 38.16K | 42.63K |
| Net Income Ratio | -42.50% | 4.38% | 33.36% | 23.64% | -12.20% | -16.08% | -37.74% | -18.19% | 80.59% | -55.03% | -78.72% | 15.12% | -59.73% | -73.79% | -86.28% | -21.37% | -88.23% | -38.04% | 1.70% | 2.03% |
| EPS | -0.01 | 0.00 | 0.01 | 0.01 | 0.00 | 0.00 | -0.01 | 0.00 | 0.01 | -0.02 | -0.02 | 0.00 | -0.03 | -0.05 | -0.14 | -0.06 | -0.21 | -0.03 | 0.03 | 0.00 |
| EPS Diluted | -0.01 | 0.00 | 0.01 | 0.01 | 0.00 | 0.00 | -0.01 | 0.00 | 0.01 | -0.02 | -0.02 | 0.00 | -0.03 | -0.05 | -0.14 | -0.06 | -0.21 | -0.03 | 0.03 | 0.00 |
| Weighted Avg Shares Out | 85.22M | 84.99M | 84.74M | 84.74M | 79.12M | 74.63M | 66.33M | 62.96M | 58.22M | 54.23M | 46.92M | 45.41M | 41.87M | 34.38M | 34.98M | 34.36M | 34.33M | 28.43M | 24.44M | 24.00M |
| Weighted Avg Shares Out (Dil) | 85.22M | 85.44M | 84.74M | 84.74M | 79.12M | 74.63M | 66.33M | 62.96M | 58.22M | 54.23M | 46.92M | 45.41M | 41.87M | 34.38M | 34.98M | 34.36M | 34.33M | 28.43M | 24.44M | 24.00M |
Reflect Scientific Inc. Secures $225,000 Order for Cutting-Edge Freezer Systems
Reflect Scientific Inc. Announces Second Quarter Sale of Groundbreaking Aerospace Manufacturing Solution
Reflect Scientific Inc. Announces Successful Testing of Liquid Nitrogen Temperature Control Technology
Reflect Scientific Inc. Announces Record-Breaking Freezer Order from a $40B BioPharma Company
Reflect Scientific Secures $200,000 Order from Prominent Bio-Pharma Client for Blast Freezers
Cryometrix Rapid Deployment Low-Temperature Chest Freezer for Vaccines
Source: https://incomestatements.info
Category: Stock Reports